ID
CAVM

Integral Derivatives’s Cavium, Inc. CAVM Stock Holding History

Integral Derivatives’s Portfolio CAVM Stock Details CAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,643
Closed -$484K – 1376
2017
Q2 		$475K Buy
+7,643
New +$534K 0.01% 719
2014
Q1 		– Sell
-10,576
Closed -$365K – 1803
2013
Q4 		$365K Buy
+10,576
New +$396K 0.01% 1157

Other funds holding CAVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Integral Derivatives's CAVM Position: Q3 2017 in Review

Integral Derivatives sold out of Cavium, Inc. (CAVM) in Q3 2017, closing a stake of 7,643 shares — an estimated $484K sold.

Integral Derivatives first reported a position in CAVM in Q4 2013 and held it in 2 quarters. The position peaked at $475K in Q2 2017. 232 funds tracked by Wall St. Rank hold CAVM as of Q3 2017.

  • Integral Derivatives reported no remaining Cavium, Inc. position as of Q3 2017 after selling out during the quarter.
  • Integral Derivatives sold 7,643 Cavium, Inc. shares in Q3 2017, an estimated $484K.
  • Integral Derivatives first reported a position in Cavium, Inc. in Q4 2013 and held it in 2 quarters.
  • Integral Derivatives's Cavium, Inc. position peaked at $475K in Q2 2017.
  • 232 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.